Eruptive melanocytic nevi during etanercept treatment in an ankylosing spondylitis patient: Case report

Eruptive melanocytic nevi (EMN) are rare multiple melanocytic lesions that rare and associated with dermatological and systemic diseases. Drug induced EMN is also reported with the use of biological or nonbiological chemotherapeutics, immunosuppressive agents, and melanocyte stimulators. In recent y...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Dermatologic therapy 2020-05, Vol.33 (3), p.e13407-n/a
Hauptverfasser:	Erdem, Yasemin, Altunay, İlknur Kıvanç, Özkur, Ezgi
Format:	Artikel
Sprache:	eng
Schlagworte:	anti‐TNF‐α agent eruptive nevi etanercept Etanercept - adverse effects Humans Immunosuppressive Agents - adverse effects Nevus, Pigmented - chemically induced Nevus, Pigmented - diagnosis Skin Neoplasms - chemically induced Skin Neoplasms - drug therapy Spondylitis, Ankylosing - diagnosis Spondylitis, Ankylosing - drug therapy Tumor Necrosis Factor-alpha
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	n/a
container_issue	3
container_start_page	e13407
container_title	Dermatologic therapy
container_volume	33
creator	Erdem, Yasemin Altunay, İlknur Kıvanç Özkur, Ezgi
description	Eruptive melanocytic nevi (EMN) are rare multiple melanocytic lesions that rare and associated with dermatological and systemic diseases. Drug induced EMN is also reported with the use of biological or nonbiological chemotherapeutics, immunosuppressive agents, and melanocyte stimulators. In recent years, the increasing use of biological drugs resulted in an increased reports of EMN induced by these drugs. The objective of this is reporting EMN in a patient receiving etanercept treatment. In addition, we also present a literature review of the previously cases with anti‐tumor necrosis factor‐α biological agents.
doi_str_mv	10.1111/dth.13407
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2390146442</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2390146442</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3207-2b670456864706037e532498e1814e2469d6bfaa8ecc83ac207df0df7c7afb723</originalsourceid><addsrcrecordid>eNp1kMtOwzAQRS0EoqWw4AeQl7BI61edmB0q5SFVYlPWketMiiEvbKcof09CCztGI80szhxpLkKXlExpX7MsvE0pFyQ-QmM6ZypKCFXH_c6VjAhTcoTOvH8nhDLF6SkaccYUTRI6Rtula5tgd4BLKHRVmy5YgyvYWZy1zlZbDEFX4Aw0AQcHOpRQBWwrrIf-6IraD5Rv6irrChusx40Otodu8UJ7wA6a2oVzdJLrwsPFYU7Q68NyvXiKVi-Pz4u7VWQ4I3HENjImYi4TKWIiCY9hzplQCdCECmBCqkxucq0TMCbh2vQ3WU6yPDaxzjcx4xN0vfc2rv5swYe0tN5A0f8GdetTxhWhQgoxoDd71Ljaewd52jhbatellKRDrmmfa_qTa89eHbTtpoTsj_wNsgdme-DLFtD9b0rv10975TfLCIMo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2390146442</pqid></control><display><type>article</type><title>Eruptive melanocytic nevi during etanercept treatment in an ankylosing spondylitis patient: Case report</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Erdem, Yasemin ; Altunay, İlknur Kıvanç ; Özkur, Ezgi</creator><creatorcontrib>Erdem, Yasemin ; Altunay, İlknur Kıvanç ; Özkur, Ezgi</creatorcontrib><description>Eruptive melanocytic nevi (EMN) are rare multiple melanocytic lesions that rare and associated with dermatological and systemic diseases. Drug induced EMN is also reported with the use of biological or nonbiological chemotherapeutics, immunosuppressive agents, and melanocyte stimulators. In recent years, the increasing use of biological drugs resulted in an increased reports of EMN induced by these drugs. The objective of this is reporting EMN in a patient receiving etanercept treatment. In addition, we also present a literature review of the previously cases with anti‐tumor necrosis factor‐α biological agents.</description><identifier>ISSN: 1396-0296</identifier><identifier>EISSN: 1529-8019</identifier><identifier>DOI: 10.1111/dth.13407</identifier><identifier>PMID: 32291881</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>anti‐TNF‐α agent ; eruptive nevi ; etanercept ; Etanercept - adverse effects ; Humans ; Immunosuppressive Agents - adverse effects ; Nevus, Pigmented - chemically induced ; Nevus, Pigmented - diagnosis ; Skin Neoplasms - chemically induced ; Skin Neoplasms - drug therapy ; Spondylitis, Ankylosing - diagnosis ; Spondylitis, Ankylosing - drug therapy ; Tumor Necrosis Factor-alpha</subject><ispartof>Dermatologic therapy, 2020-05, Vol.33 (3), p.e13407-n/a</ispartof><rights>2020 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3207-2b670456864706037e532498e1814e2469d6bfaa8ecc83ac207df0df7c7afb723</cites><orcidid>0000-0002-6597-2957 ; 0000-0002-9136-7021</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fdth.13407$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fdth.13407$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,778,782,1414,27911,27912,45561,45562</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32291881$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Erdem, Yasemin</creatorcontrib><creatorcontrib>Altunay, İlknur Kıvanç</creatorcontrib><creatorcontrib>Özkur, Ezgi</creatorcontrib><title>Eruptive melanocytic nevi during etanercept treatment in an ankylosing spondylitis patient: Case report</title><title>Dermatologic therapy</title><addtitle>Dermatol Ther</addtitle><description>Eruptive melanocytic nevi (EMN) are rare multiple melanocytic lesions that rare and associated with dermatological and systemic diseases. Drug induced EMN is also reported with the use of biological or nonbiological chemotherapeutics, immunosuppressive agents, and melanocyte stimulators. In recent years, the increasing use of biological drugs resulted in an increased reports of EMN induced by these drugs. The objective of this is reporting EMN in a patient receiving etanercept treatment. In addition, we also present a literature review of the previously cases with anti‐tumor necrosis factor‐α biological agents.</description><subject>anti‐TNF‐α agent</subject><subject>eruptive nevi</subject><subject>etanercept</subject><subject>Etanercept - adverse effects</subject><subject>Humans</subject><subject>Immunosuppressive Agents - adverse effects</subject><subject>Nevus, Pigmented - chemically induced</subject><subject>Nevus, Pigmented - diagnosis</subject><subject>Skin Neoplasms - chemically induced</subject><subject>Skin Neoplasms - drug therapy</subject><subject>Spondylitis, Ankylosing - diagnosis</subject><subject>Spondylitis, Ankylosing - drug therapy</subject><subject>Tumor Necrosis Factor-alpha</subject><issn>1396-0296</issn><issn>1529-8019</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtOwzAQRS0EoqWw4AeQl7BI61edmB0q5SFVYlPWketMiiEvbKcof09CCztGI80szhxpLkKXlExpX7MsvE0pFyQ-QmM6ZypKCFXH_c6VjAhTcoTOvH8nhDLF6SkaccYUTRI6Rtula5tgd4BLKHRVmy5YgyvYWZy1zlZbDEFX4Aw0AQcHOpRQBWwrrIf-6IraD5Rv6irrChusx40Otodu8UJ7wA6a2oVzdJLrwsPFYU7Q68NyvXiKVi-Pz4u7VWQ4I3HENjImYi4TKWIiCY9hzplQCdCECmBCqkxucq0TMCbh2vQ3WU6yPDaxzjcx4xN0vfc2rv5swYe0tN5A0f8GdetTxhWhQgoxoDd71Ljaewd52jhbatellKRDrmmfa_qTa89eHbTtpoTsj_wNsgdme-DLFtD9b0rv10975TfLCIMo</recordid><startdate>202005</startdate><enddate>202005</enddate><creator>Erdem, Yasemin</creator><creator>Altunay, İlknur Kıvanç</creator><creator>Özkur, Ezgi</creator><general>John Wiley & Sons, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6597-2957</orcidid><orcidid>https://orcid.org/0000-0002-9136-7021</orcidid></search><sort><creationdate>202005</creationdate><title>Eruptive melanocytic nevi during etanercept treatment in an ankylosing spondylitis patient: Case report</title><author>Erdem, Yasemin ; Altunay, İlknur Kıvanç ; Özkur, Ezgi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3207-2b670456864706037e532498e1814e2469d6bfaa8ecc83ac207df0df7c7afb723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>anti‐TNF‐α agent</topic><topic>eruptive nevi</topic><topic>etanercept</topic><topic>Etanercept - adverse effects</topic><topic>Humans</topic><topic>Immunosuppressive Agents - adverse effects</topic><topic>Nevus, Pigmented - chemically induced</topic><topic>Nevus, Pigmented - diagnosis</topic><topic>Skin Neoplasms - chemically induced</topic><topic>Skin Neoplasms - drug therapy</topic><topic>Spondylitis, Ankylosing - diagnosis</topic><topic>Spondylitis, Ankylosing - drug therapy</topic><topic>Tumor Necrosis Factor-alpha</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Erdem, Yasemin</creatorcontrib><creatorcontrib>Altunay, İlknur Kıvanç</creatorcontrib><creatorcontrib>Özkur, Ezgi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Dermatologic therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Erdem, Yasemin</au><au>Altunay, İlknur Kıvanç</au><au>Özkur, Ezgi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Eruptive melanocytic nevi during etanercept treatment in an ankylosing spondylitis patient: Case report</atitle><jtitle>Dermatologic therapy</jtitle><addtitle>Dermatol Ther</addtitle><date>2020-05</date><risdate>2020</risdate><volume>33</volume><issue>3</issue><spage>e13407</spage><epage>n/a</epage><pages>e13407-n/a</pages><issn>1396-0296</issn><eissn>1529-8019</eissn><abstract>Eruptive melanocytic nevi (EMN) are rare multiple melanocytic lesions that rare and associated with dermatological and systemic diseases. Drug induced EMN is also reported with the use of biological or nonbiological chemotherapeutics, immunosuppressive agents, and melanocyte stimulators. In recent years, the increasing use of biological drugs resulted in an increased reports of EMN induced by these drugs. The objective of this is reporting EMN in a patient receiving etanercept treatment. In addition, we also present a literature review of the previously cases with anti‐tumor necrosis factor‐α biological agents.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>32291881</pmid><doi>10.1111/dth.13407</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-6597-2957</orcidid><orcidid>https://orcid.org/0000-0002-9136-7021</orcidid><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1396-0296
ispartof	Dermatologic therapy, 2020-05, Vol.33 (3), p.e13407-n/a
issn	1396-0296 1529-8019
language	eng
recordid	cdi_proquest_miscellaneous_2390146442
source	MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects	anti‐TNF‐α agent eruptive nevi etanercept Etanercept - adverse effects Humans Immunosuppressive Agents - adverse effects Nevus, Pigmented - chemically induced Nevus, Pigmented - diagnosis Skin Neoplasms - chemically induced Skin Neoplasms - drug therapy Spondylitis, Ankylosing - diagnosis Spondylitis, Ankylosing - drug therapy Tumor Necrosis Factor-alpha
title	Eruptive melanocytic nevi during etanercept treatment in an ankylosing spondylitis patient: Case report
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T22%3A09%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Eruptive%20melanocytic%20nevi%20during%20etanercept%20treatment%20in%20an%20ankylosing%20spondylitis%20patient:%20Case%20report&rft.jtitle=Dermatologic%20therapy&rft.au=Erdem,%20Yasemin&rft.date=2020-05&rft.volume=33&rft.issue=3&rft.spage=e13407&rft.epage=n/a&rft.pages=e13407-n/a&rft.issn=1396-0296&rft.eissn=1529-8019&rft_id=info:doi/10.1111/dth.13407&rft_dat=%3Cproquest_cross%3E2390146442%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2390146442&rft_id=info:pmid/32291881&rfr_iscdi=true